COLACI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 6.349
AS - Asia 3.242
EU - Europa 2.493
SA - Sud America 522
AF - Africa 337
OC - Oceania 2
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.947
Nazione #
US - Stati Uniti d'America 6.131
SG - Singapore 1.867
RU - Federazione Russa 913
CN - Cina 758
IE - Irlanda 490
IT - Italia 487
BR - Brasile 434
VN - Vietnam 199
FR - Francia 167
CI - Costa d'Avorio 154
CA - Canada 152
NG - Nigeria 111
KR - Corea 104
UA - Ucraina 88
GB - Regno Unito 76
IN - India 63
DE - Germania 55
BD - Bangladesh 53
MX - Messico 33
AR - Argentina 30
HK - Hong Kong 28
NL - Olanda 28
IQ - Iraq 26
SE - Svezia 26
FI - Finlandia 24
PL - Polonia 23
CH - Svizzera 19
ES - Italia 19
AT - Austria 17
EC - Ecuador 16
JP - Giappone 16
ZA - Sudafrica 16
ID - Indonesia 15
SN - Senegal 14
TR - Turchia 13
UZ - Uzbekistan 13
CZ - Repubblica Ceca 11
BJ - Benin 10
CO - Colombia 10
GR - Grecia 10
LB - Libano 10
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
IR - Iran 9
MA - Marocco 9
PY - Paraguay 8
SA - Arabia Saudita 8
JM - Giamaica 7
KE - Kenya 7
LT - Lituania 7
VE - Venezuela 7
DO - Repubblica Dominicana 6
TT - Trinidad e Tobago 6
BE - Belgio 5
BO - Bolivia 5
CL - Cile 5
MY - Malesia 5
CR - Costa Rica 4
GT - Guatemala 4
HU - Ungheria 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
RO - Romania 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
HN - Honduras 3
IL - Israele 3
OM - Oman 3
RS - Serbia 3
AU - Australia 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
LK - Sri Lanka 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 12.936
Città #
Singapore 1.120
Dallas 916
Santa Clara 871
Chandler 736
Dublin 490
San Jose 459
Ashburn 330
Moscow 305
Chicago 199
Houston 176
Boardman 165
New York 156
Abidjan 154
Los Angeles 139
Lauterbourg 128
Hefei 127
Lawrence 126
Cambridge 122
Andover 120
Beijing 115
Nanjing 115
Seoul 103
Catania 98
Jacksonville 84
Toronto 79
Des Moines 76
Lagos 66
Ho Chi Minh City 60
Council Bluffs 54
São Paulo 42
Hanoi 41
Wilmington 40
Civitanova Marche 35
The Dalles 35
Columbus 34
Ottawa 32
Abuja 29
Saint Petersburg 29
Buffalo 27
Shenyang 27
Palermo 26
Hong Kong 25
Jiaxing 25
Milan 25
Nanchang 25
Orem 25
Hebei 23
Bremen 22
Falls Church 22
Rome 21
Ann Arbor 20
Warsaw 18
Brooklyn 17
Kochi 17
Montreal 17
Chennai 16
Port Harcourt 16
Denver 15
Poplar 15
Tianjin 15
Atlanta 14
Belo Horizonte 14
Dakar 14
Mexico City 14
Tokyo 14
Amsterdam 13
Changsha 13
Rio de Janeiro 13
San Francisco 13
Seattle 13
Stockholm 13
Haiphong 11
Lappeenranta 11
London 11
Washington 11
Boston 10
Cotonou 10
Da Nang 10
Jesi 10
Johannesburg 10
Turin 10
Bari 9
Brno 9
Jakarta 9
Kunming 9
Norwalk 9
Nuremberg 9
Phoenix 9
Tehran 9
Guangzhou 8
Hải Dương 8
Jinan 8
Quito 8
Baghdad 7
Calgary 7
Cesa 7
Frankfurt am Main 7
Manchester 7
Paterno 7
Reggio Emilia 7
Totale 8.870
Nome #
COVID-19-related retinal microvasculopathy and systemic implications in patients with severe disease: results from the Methuselah study 196
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 179
Endocrine disorders associated with hepatitis C virus chronic infection 161
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 155
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 153
"Usual" interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 140
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection 138
Cardiovascular risk and prostanoids in systemic sclerosis 132
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 130
COMPARISON BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A PROSPECTIVE COHORT 129
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 127
[CXCR3 and CXCL10 in autoimmune thyroiditis] 127
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 127
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection and HCV extrahepatic manifestations 127
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them? 127
Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients 126
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 123
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 119
Aortic pulse wave velocity measurement in systemic sclerosis patients 118
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 118
ADHERENCE TO THERAPY IN RHEUMATIC PATIENTS TREATED WITH SUBCUTANEOUS BIOLOGICS 118
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 117
Associations between Systemic Sclerosis and Thyroid Diseases 117
Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants 116
Reduction of carotid baroreceptor sensitivity in systemic sclerosis 115
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS 115
Cardiac involvement in systemic sclerosis: Identification of high-risk patient profiles in different patterns of clinical presentation 115
Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients 113
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 112
Assessing Humoral Immuno-Inflammatory Pathways Associated with Respiratory Failure in COVID-19 Patients 111
Heart Valve Abnormalities in Systemic Sclerosis Patients: A Multicenter Cohort Study and Review of the Literature 111
The Impaired Elasticity of Large Arteries in Systemic Sclerosis Patients 110
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 110
The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features 109
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 108
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 107
Vasculiti sistemiche 106
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 105
Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study 102
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 99
Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review 98
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 98
Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature 97
Heart involvement and systemic sclerosis 97
Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience 96
Etiopathogenesis of Systemic Sclerosis: Role of Human Parvovirus B19 93
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 93
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 92
Elevated Troponin Serum Levels in Adult Onset Still's Disease 92
Nailfold videocapillaroscopy alterations in dermatomyositis and systemic sclerosis: Toward identification of a specific pattern 92
Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature 91
Novel Therapies for Thyroid Autoimmune Diseases 91
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study 91
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 91
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 90
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis 90
Vascular dysfunction of COVID-19 is partially reverted in the long-term 89
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. 88
Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: A multicentre validation study 88
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 86
Impegno cardiaco nella sclerosi sistemica 85
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 85
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 85
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 83
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 83
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 83
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 83
Paraneoplastic rheumatic disorders: a narrative review 83
The Pattern and Progression of "Usual" Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 82
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 82
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 82
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 82
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 82
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers 81
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 81
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 81
Osteomyelitis complicating scleroderma digital ulcers 81
HCV-related autoimmune disorders in HCV chronic infection. 81
LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSIS MANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 81
IP-10 in autoimmune thyroiditis 80
Viral infections and systemic sclerosis. 80
Serum a-Chemokine CXCL10 and b-Chemokine CCL2 Levels in HCV-Positive Cryoglobulinemia 80
The safety of iloprost in systemic sclerosis in a real-life experience 79
Platelet gel in the treatment of severe scleroderma skin ulcers 79
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 79
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature 78
Storia naturale della sclerosi sistemica in Italia. 78
Severe alopecia complicating systemic sclerosis 77
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature 77
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 77
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report 77
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 77
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 77
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus 77
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 77
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 76
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 75
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 75
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 75
Thymus alterations and systemic sclerosis 74
Totale 10.001
Categoria #
all - tutte 48.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022816 77 126 2 6 143 12 127 31 34 9 26 223
2022/20231.838 139 80 57 182 185 329 10 265 458 18 65 50
2023/2024652 47 97 30 27 25 145 3 49 7 21 136 65
2024/20253.005 22 373 170 136 645 417 91 80 269 287 310 205
2025/20265.860 354 288 992 298 1.023 1.063 789 108 309 314 163 159
2026/202783 83 0 0 0 0 0 0 0 0 0 0 0
Totale 13.267